Wize Pharma (Israel) Alpha and Beta Analysis Overview

WIZP -- Israel Stock  

ILS 213.00  10.20  5.03%

This module allows you to check different measures of market premium for Wize Pharma as well as systematic risk associated with investing in Wize Pharma over a specified time horizon. See also Your Current Watchlist.
Horizon     30 Days    Login   to change
Run Premiums

Wize Pharma Market Premiums

30 days against DJI
Risk Adjusted Performance  


Jensen Alpha  


Total Risk Alpha  


Sortino Ratio  


Treynor Ratio  


Wize Pharma Fundamentals

 Better Than Average     
 Worse Than Average Compare Wize Pharma to competition

Wize Pharma Fundamental Vs Peers

FundamentalsWize PharmaPeer Average
Return On Asset(80.74) % (15.64) %
Current Valuation35.93 M152.14 B
Shares Outstanding22.67 M1.43 B
Price to Book2,903 times14.44 times
EBITDA(1.31 M)1.41 B
Net Income(1.91 M)517.71 M
Cash and Equivalents275 K3.89 B

Wize Pharma Opportunities

Wize Pharma Return and Market Media

 Price Growth (%)  

Current Sentiment - WIZP

Wize Pharma Investor Sentiment

Macroaxis portfolio users are unemotional in their outlook on investing in Wize Pharma. What is your outlook on investing in Wize Pharma? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
See also Your Current Watchlist. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com